All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - COVID
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Read more...
https://pubmed.ncbi.nlm.nih.gov/32339221/
Read more...
Hematological findings and complications of COVID-19
Read more...
Coagulopathy of COVID-19 and antiphospholipid antibodies
Read more...
The versatile heparin in COVID-19
Read more...
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Read more...
Hypoxia-An overlooked trigger for thrombosis in COVID-19 and other critically ill patients
Read more...
A proposal for staging COVID-19 coagulopathy
Read more...
COVID-19-associated coagulopathy: An exploration of mechanisms
Read more...
Understanding the COVID-19 coagulopathy spectrum
Read more...
The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states
Read more...
Emergence of institutional antithrombotic protocols for coronavirus 2019
Read more...
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Read more...
COVID‐19: A collision of complement, coagulation and inflammatory pathways
Read more...
Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients
Read more...
COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy
Read more...
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)
Read more...
Dramatic presentation of acquired thombotic thrombocytopenic purpura associated with COVID-19
Read more...
D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?
Read more...
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Read more...
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Read more...
Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2
Read more...
Potential of heparin and nafamostat combination therapy for COVID-19
Read more...
Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study
Read more...
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Read more...
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Read more...
COVID-19 and acute coagulopathy in pregnancy
Read more...
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Read more...
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19
Read more...
Kawasaki-like disease: emerging complication during the COVID-19 pandemic
Read more...
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Read more...
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Read more...
COVID-19 coagulopathy: an evolving story
Read more...
Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis
Read more...
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
Read more...
SARS-CoV-2 and Stroke in a New York Healthcare System
Read more...
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
Read more...
Prevalence, specificity, and clinical association of anti-phospholipid antibodies in COVID-19 patients: are the antibodies really guilty?
Read more...
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis
Read more...
Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation
Read more...
Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy
Read more...
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19
Read more...
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Read more...
Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis
Read more...
Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19
Read more...
Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports
Read more...
Response to "All these D-dimers in COVID-19"
Read more...
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Read more...
Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation
Read more...
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology
Read more...
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
Read more...
Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications
Read more...
COVID-19 update: Covid-19-associated coagulopathy
Read more...
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
Read more...
Heparin resistance in COVID-19 patients in the intensive care unit
Read more...
Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands
Read more...
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
Read more...
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series
Read more...
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Read more...
Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily
Read more...
Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review
Read more...
Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience
Read more...
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation
Read more...
Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia
Read more...
Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays
Read more...
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis
Read more...
Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
Read more...
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
Read more...
The contact activation system as a potential therapeutic target in patients with COVID‐19
Read more...
Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients
Read more...
COVID-19-Related Aortic Thrombosis: A Report of Four Cases
Read more...
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report
Read more...
Airway proteases: an emerging drug target for influenza and other respiratory virus infections
Read more...
COVID-19 hypothesis: Activated protein C for therapy of virus-induced pathologic thromboinflammation
Read more...
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Read more...
Clinically significant anticardiolipin antibodies associated with COVID-19
Read more...
Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients
Read more...
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Read more...
Consumptive Coagulopathy and Thrombosis during Severe COVID-19 Infection: Potential Involvement of VWF/ADAMTS13
Read more...
Severe COVID-19 infection associated with endothelial activation
Read more...
Incidence of venous thromboembolism in hospitalized patients with COVID-19
Read more...
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Read more...
Staging Severity of COVID-19 according to Hemostatic Abnormalities (CAHA Score)
Read more...
Pulmonary embolism during the COVID-19 pandemic: Decline in diagnostic procedures and incidence at a university hospital
Read more...
ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients
Read more...
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Read more...
Hemostatic laboratory derangements in COVID-19 with a focus on platelet count
Read more...
Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19
Read more...
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19
Read more...
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
Read more...
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Read more...
Laboratory abnormalities in patients with COVID-2019 infection
Read more...
Clinical management of severe acute respiratory infection when COVID-19 is suspected (v1.2)
Read more...
Essential Role of Patient Blood Management in a Pandemic: A Call for Action
Read more...
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure
Read more...
Viscoelastic testing in COVID-19: a possible screening tool for severe disease?
Read more...
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
Read more...
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
Read more...
High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?
Read more...
Start
Prev
1
2
3
Next
End
Page 2 of 3
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection